• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Introducing Inizio: Ashfield and Huntsworth Unite Expertise to Form Strategic Partner

Article

Ashfield and Huntsworth unite their full suite of advisory, medical, marketing, communications and patient and stakeholder engagement services to create Inizio, a strategic partner to health and life science companies throughout the life cycle of their drug products.

Operating from 35 countries with a team of 10,000+ employees and an unparalleled number of strategic, scientific, medical and creative experts, Inizio connects the capabilities to support its clients with transformative go-to-market solutions across all therapeutic areas.

“The creation of Inizio is a direct response to the increasingly complex landscape our clients navigate in terms of clinical development, product launch and commercialization. Through Inizio they can access the specialist expertise and a partner that will help them to optimize the commercialization of their products.

Inizio launches with five specialist business units that provide a suite of capabilities from landscape assessment to loss of exclusivity: Inizio Advisory: Inizio Medical, Inizio MarComms, Inizio Engage, and Inizio Biotech.

Recent Videos
Related Content